John Thornback

Title: Innovations of John Thornback

Introduction

John Thornback is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of diagnostic imaging, holding three patents that showcase his innovative work. His inventions focus on developing advanced imaging agents that can aid in the diagnosis of various medical conditions.

Latest Patents

One of Thornback's latest patents is for non-receptor cell mediated imaging agents. These detectably labeled non-receptor mediated cell-associating compounds are designed for use in the diagnostic imaging of target sites in mammals. The compounds can be directly labeled or labeled via a chelating compound to form a conjugate. This technology is particularly useful for imaging target sites such as tumor sites and sites of infection. Another significant patent involves radiolabeled D4 receptor ligands. This invention describes radiolabeled compounds and their precursors that are useful for imaging D4 receptors in vivo. The compounds can aid in diagnosing schizophrenia and other medical conditions where the D4 receptor is implicated.

Career Highlights

John Thornback is currently associated with Resolution Pharmaceuticals Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the capabilities of diagnostic imaging, making it more effective for medical professionals.

Collaborations

Thornback has collaborated with notable colleagues, including Alfred Pollak and Susan H Peers. These partnerships have contributed to the success of his projects and the advancement of their shared goals in the field of medical imaging.

Conclusion

John Thornback's innovative contributions to diagnostic imaging through his patents reflect his dedication to improving medical technology. His work continues to have a significant impact on the field, aiding in the diagnosis and treatment of various medical conditions.